Literature DB >> 21613437

Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.

Jeffrey J Germer1, Jayawant N Mandrekar, Jordan L Bendel, P Shawn Mitchell, Joseph D C Yao.   

Abstract

Hepatitis C virus (HCV) genotype (GT) distribution and frequency were studied among 22,407 unique specimens tested at a national reference testing laboratory. Subjects with HCV GT 3 were younger (P < 0.0001) than those with GT 1, 2, or 4, and the regional frequencies of HCV GT 2 and 3 ranged from 19.9% to 29.2%.

Entities:  

Mesh:

Year:  2011        PMID: 21613437      PMCID: PMC3147781          DOI: 10.1128/JCM.00457-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Authors:  G L Armstrong; M J Alter; G M McQuillan; H S Margolis
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center.

Authors:  H E Vargas; L F Wang; T Laskus; A Poutous; R Lee; A Demetris; F Dodson; A Casavilla; J Fung; T Gayowski; N Singh; I Marino; J Rakela
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 4.  Prevention of spread of hepatitis C.

Authors:  Miriam J Alter
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.

Authors:  Ian T Williams; Beth P Bell; Wendi Kuhnert; Miriam J Alter
Journal:  Arch Intern Med       Date:  2011-02-14

6.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.

Authors:  N N Zein; J Rakela; E L Krawitt; K R Reddy; T Tominaga; D H Persing
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

7.  Genotypic analysis of hepatitis C virus in American patients.

Authors:  K Mahaney; V Tedeschi; G Maertens; A M Di Bisceglie; J Vergalla; J H Hoofnagle; R Sallie
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

8.  Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

Authors:  J Y Lau; G L Davis; L E Prescott; G Maertens; K L Lindsay; K Qian; M Mizokami; P Simmonds
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391

9.  Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region.

Authors:  Frederick S Nolte; Alicia M Green; Kristin R Fiebelkorn; Angela M Caliendo; Cynthia Sturchio; Aileen Grunwald; Mimi Healy
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

10.  Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b.

Authors:  Zhenyu Chen; Karen E Weck
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more
  13 in total

1.  Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.

Authors:  Stuart C Gordon; Sheri Trudeau; Jia Li; Yueren Zhou; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Joseph A Boscarino; Yihe G Daida; Mark A Schmidt; Mei Lu
Journal:  J Clin Gastroenterol       Date:  2019-01       Impact factor: 3.062

Review 2.  Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C.

Authors:  Karoll J Cortez; Shyam Kottilil
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

3.  Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.

Authors:  Mei Yu; Betty Peng; Katie Chan; Ruoyu Gong; Huiling Yang; William Delaney; Guofeng Cheng
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

4.  Patient Characteristics and Prescribing Patterns Associated with Sofosbuvir Treatment for Chronic HCV Infection in a Commercially Insured Population.

Authors:  Brent M Tambourine; Arash Sadeghi; Jianing Yang; Karen M Stockl; Heidi C Lew; Brian K Solow; Josephine N Tran
Journal:  Am Health Drug Benefits       Date:  2016-04

5.  Hepatitis C virus genotypes in north eastern Algeria: A retrospective study.

Authors:  Samir Rouabhia; Mourad Sadelaoud; Karima Chaabna-Mokrane; Wided Toumi; Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2013-07-27

6.  Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.

Authors:  Paulo Telles Dias; Judith A Hahn; Eric Delwart; Brian Edlin; Jeff Martin; Paula Lum; Jennifer Evans; Alex Kral; Steve Deeks; Michael P Busch; Kimberly Page
Journal:  BMC Infect Dis       Date:  2011-08-02       Impact factor: 3.090

Review 7.  Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.

Authors:  Kristen Brown; Martin LaBrie; Carla S Coffin
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.495

8.  Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Aghnaya A Dau
Journal:  BMC Res Notes       Date:  2015-08-21

9.  Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes.

Authors:  Lauren E Cipriano; Shan Liu; Kaspar S Shahzada; Mark Holodniy; Jeremy D Goldhaber-Fiebert
Journal:  Med Decis Making       Date:  2018-08-22       Impact factor: 2.583

10.  Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.

Authors:  Sandra De Meyer; Anne Ghys; Inge Dierynck; Maria Beumont; Donghan Luo; Gaston Picchio
Journal:  Virol J       Date:  2014-05-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.